LIFERIVER(688317.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
LIFERIVER
688317.SH
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.
303.05 B
688317.SHMarket value -Rank by Market Cap -/-

Financial Score

09/06/2026 Update
D
Health Care SuppliesIndustry
Industry Ranking38/40
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-1.28%D
    • Profit Margin-37.08%E
    • Gross Margin68.86%A
  • Growth ScoreD
    • Revenue YoY-25.98%E
    • Net Profit YoY74.30%A
    • Total Assets YoY-1.77%D
    • Net Assets YoY-6.49%D
  • Cash ScoreE
    • Cash Flow Margin-139.74%E
    • OCF YoY-25.98%E
  • Operating ScoreE
    • Turnover0.03E
  • Debt ScoreA
    • Gearing Ratio10.90%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily limit up in the afternoon. LIFERIVER and DAJY had previously reached their limit up, while WONDFO BIOTECH, ACROBIOSYSTEMS, Orient Biotech, and SSSW rose over 10%

    Wallstreetcn·
    SH
    688317
    -2.63%
    SZ
    002022
    -2.34%
    SZ
    301080
    -0.73%
    Wallstreetcn·
    SH
    688317
    -2.63%
    SZ
    002022
    -2.34%
    SZ
    301080
    -0.73%

    LIFERIVER obtained a medical device registration certificate

    Zhitong·
    SH
    688317
    -2.63%
    Zhitong·
    SH
    688317
    -2.63%

    LIFERIVER released its performance for the first three quarters, with a net loss attributable to the parent company of 29.38 million yuan

    Zhitong·
    SH
    688317
    -2.63%
    Zhitong·
    SH
    688317
    -2.63%

    LIFERIVER: Plans to repurchase shares for 60 million to 120 million yuan

    Zhitong·
    SH
    688317
    -2.63%
    Zhitong·
    SH
    688317
    -2.63%

    LIFERIVER: Monkeypox virus nucleic acid testing kit (fluorescent PCR method) included in WHO emergency use list

    Zhitong·
    SH
    688317
    -2.63%
    Zhitong·
    SH
    688317
    -2.63%
    © 2026 Longbridge｜Disclaimer